Home / Medical Devices / Asthma Spacers Market By Product (Aerochamber, Inspirease, Optichamber and Volumatic), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy and E-Commerce) - Growth, Future Prospects & Competitive Analysis, 2018 – 2026

Asthma Spacers Market By Product (Aerochamber, Inspirease, Optichamber and Volumatic), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy and E-Commerce) - Growth, Future Prospects & Competitive Analysis, 2018 – 2026

Published: Mar 2019 | Report Code: 59628-03-19

The asthma spacers market is set to reach from US$ 1,311.1 Mn in 2017 to US$ 1,824.4 Mn by 2026 at a compound annual growth rate (CAGR) of 3.8% during the forecast period from 2018 to 2026. As per the latest research citings of World Health Organization (WHO), approximately 235 million people worldwide are suffering with asthma and by 2025 an additional increase of 100 million is expected. Asthma spacers are beneficial in mitigating dosing discrepancies associated with inhalers and nebulizers.

Market Synopsis

Asthma Spacers Market

Get a sample copy for more information

"Technological advancement and excellent control and coordination obtained while using metered dose inhalers increase the popularity for aerochambers"

Aerochamber is reigning the product segment for asthma spacers market. Latest technological advancement and excellent control and coordination achieved by patient while using metered dose inhalers drive the aerochamber market growth. It has greater adoption rate as it is available in different mask size to fit patients belonging to different age group. Inspirease have gained acknowledgement in the recent years as it is beneficial in increasing the distance between MDI and mouth, thereby lowering the inhalation of propellants in the oropharyngeal region.

Asthma Spacers Market

"Establishment of premium medicine and significant rise in the launch of professionalized pharmacy chains will provide thrust to retail pharmacy market growth"

Retail pharmacy is dominating the distribution channel segment for asthma spacers market. Establishment of premium medicine and significant rise in the number of pharmacy chains worldwide will provide positive impetus to the retail pharmacy market growth. Increasing demand for metered dose inhalers has led to rise in the over the counter (OTC) sales for asthma spacers in retail pharmacy. E-commerce will capture the market during the forecast period owing to availability of low priced asthma spacers in comparison to retail stores due to low overhead cost. Domestic and international vendors exhibit their product online which provides more options to consumers. Increasing adoption of digital products by consumers facilitates the e-commerce market growth. 

Asthma Spacers Market

Get a sample copy for more information

"Rising prevalence of asthma and domicile of key players drive the asthma spacers market growth"

In the present scenario with 34% market share North America is the largest regional segment for asthma spacers market. According to Center for Disease Control and Prevention (CDC) statistics in 2017, the percentage of children under 18 years of age suffering with asthma was 8.4%. Rising prevalence of asthma and domicile of key players such as Allergan, Inc., CONMED Corporation, Trudell Medical International etc. drive the asthma spacers market growth in North America region. Europe is in the second position with 26% market share primarily due to supportive regulatory environment provided by European Medical Agency (EMA) for manufacturing and sale of asthma spacers. Asia Pacific represents 16% market growth and will garner stable growth in the near future due to rising prevalence of respiratory disorders and well established e-commerce sector.

Asthma Spacers Market 

Get a sample copy for more information

Historical & Forecast Period

This research report presents the analysis of each segment from 2016 to 2026 considering 2017 as the base year for the research. Compounded annual growth rate (CAGR) for each respective segments are calculated for the forecast period from 2018 to 2026.

Report Scope by Segments

The market segmentation comprises of by product, by distribution channel and geography.

ATTRIBUTE DETAILS
Research Period  2017-2027
Base Year 2018
Forecast Period  2019-2027
Historical Year  2017
Unit  USD Million
Segmentation

 By Product (2016–2026; US$ Mn)
 • Aerochamber
 • Inspirease
 • Optichamber
 • Volumatic

 By Distribution Channel (2016–2026; US$ Mn)
 • Hospital Pharmacy
 • Retail Pharmacy
 • E-Commerce

 Geography Segment (2016–2026; US$ Mn)
 • North America (U.S., Canada)
 • Europe (U.K., Germany, Rest of Europe)
 • Asia Pacific (China, Japan, Rest of Asia Pacific)
 • Latin America (Brazil, Mexico, Rest of Latin America)
 • Middle East and Africa (GCC, Rest of MEA)

Medical device manufacturers producing asthma spacers are AstraZeneca, Plc., Allergan, Inc., CONMED Corporation, Clement Clarke International Limited, GlaxoSmithkline, Plc., Koninklijke Philips N.V., Medical Developments International, Merck & Co., Inc., PARI Respiratory Equipment, Inc. and Trudell Medical International.

Key questions answered in this report

  • Who are the major players actively engaged in asthma spacers market?
  • What are the drivers, opportunities and limitations associated with asthma spacers market?
  • What is the disease etiology associated with asthma and problems encountered in drug dosing of metered dose inhalers?
  • What will be the market size and CAGR of aerochambers during the forecast period?
  • What will be the market performance of e-commerce sector in the near future?
  • What is the asthma prevalence rate in North America for asthma spacers market?

Chapter 1. Preface
1.1. Report Scope and Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I-Secondary Research
1.3.2. Phase II-Primary Research
1.3.3. Approach Adopted
1.3.4. Top-down Approach
1.3.5. Bottom-up Approach
1.3.6. Phase III-Expert Panel Review
1.3.7. Assumptions
1.4. Market Segmentation

Chapter 2. Executive Summary
2.1. Global AS Market Portraiture
2.2. Global AS Market, by Product, 2017 (US$ Mn)
2.3. Global AS Market, by Distribution Channel, 2017 (US$ Mn)
2.4. Global AS Market, by Geography, 2017 (US$ Mn)

Chapter 3. Asthma Spacers (AS) Market: Dynamics and Future Outlook
3.1. Market Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.5. Attractive Investment Proposition, by Geography, 2017
3.6. Competitive Analysis: Global AS Market, by Key Players, 2017

Chapter 4. Global Asthma Spacers (AS) Market, by Product
4.1. Overview
4.2. Aerochamber
4.3. Inspirease
4.4. Optichamber
4.5. Volumatic

Chapter 5. Global Asthma Spacers (AS) Market, by Distribution Channel
5.1. Overview
5.2. Hospital Pharmacy
5.3. Retail Pharmacy
5.4. E-Commerce

Chapter 6. Global Asthma Spacers (AS) Market, by Geography
6.1. Overview
6.2. North America AS Market Analysis, 2016 – 2026
6.2.1. North America AS Market, by Product, 2016 – 2026 (US$ Mn)
6.2.2. North America AS Market, by Distribution Channel, 2016 – 2026 (US$ Mn)
6.2.3. North America AS Market, by Country, 2016 – 2026 (US$ Mn)
6.2.3.1. U.S.
6.2.3.2. Canada
6.3. Europe AS Market Analysis, 2016 – 2026
6.3.1. Europe AS Market, by Product, 2016 – 2026 (US$ Mn)
6.3.2. Europe AS Market, by Distribution Channel, 2016 – 2026 (US$ Mn)
6.3.3. Europe AS Market, by Country/Region, 2016 – 2026 (US$ Mn)
6.3.3.1. U.K.
6.3.3.2. Germany
6.3.3.3. Rest of Europe
6.4. Asia Pacific AS Market Analysis, 2016 – 2026
6.4.1. Asia Pacific AS Market, by Product, 2016 – 2026 (US$ Mn)
6.4.2. Asia Pacific AS Market, by Distribution Channel, 2016 – 2026 (US$ Mn)
6.4.3. Asia Pacific AS Market, by Country/Region, 2016 – 2026 (US$ Mn)
6.4.3.1. China
6.4.3.2. Japan
6.4.3.3. Rest of Asia Pacific
6.5. Latin America AS Market Analysis, 2016 – 2026
6.5.1. Latin America AS Market, by Product, 2016 – 2026 (US$ Mn)
6.5.2. Latin America AS Market, by Distribution Channel, 2016 – 2026 (US$ Mn)
6.5.3. Latin America AS Market, by Country/Region, 2016 – 2026 (US$ Mn)
6.5.3.1. Brazil
6.5.3.2. Mexico
6.5.3.3. Rest of Latin America
6.6. Middle East and Africa AS Market Analysis, 2016 – 2026
6.6.1. MEA AS Market, by Product, 2016 – 2026 (US$ Mn)
6.6.2. MEA AS Market, by Distribution Channel, 2016 – 2026 (US$ Mn)
6.6.3. MEA AS Market, by Country/Region, 2016 – 2026 (US$ Mn)
6.6.3.1. GCC
6.6.3.2. Rest of MEA

Chapter 7. Company Profiles
7.1. AstraZeneca, Plc.
7.1.1. Business Description
7.1.2. Financial Information (Subject to data availability)
7.1.3. Product Portfolio
7.1.4. News Coverage
7.2. Allergan, Inc.
7.3. CONMED Corporation
7.4. Clement Clarke International Limited
7.5. GlaxoSmithkline, Plc.
7.6. Koninklijke Philips N.V.
7.7. Medical Developments International
7.8. Merck & Co., Inc.
7.9. PARI Respiratory Equipment, Inc.
7.10. Trudell Medical International

* AS - Asthma Spacers

FIG. 1 Asthma Spacers (AS) Market: Research Methodology
FIG. 2 AS: Market Segmentation
FIG. 3 Global AS Market, by Product, 2017 (US$ Mn)
FIG. 4 Global AS Market, by Distribution Channel, 2017 (US$ Mn)
FIG. 5 Global AS Market, by Geography, 2017 (US$ Mn)
FIG. 6 Attractive Investment Proposition: by Geography, 2017
FIG. 7 Competitive Analysis: Global AS Market, by Key Players, 2017
FIG. 8 Global Aerochamber Market for AS, 2016 – 2026 (US$ Mn)
FIG. 9 Global Inspirease Market for AS, 2016 – 2026 (US$ Mn)
FIG. 10 Global Optichamber Market for AS, 2016 – 2026 (US$ Mn)
FIG. 11 Global Volumatic Market for AS, 2016 – 2026 (US$ Mn)
FIG. 12 Global Hospital Pharmacy Market for AS, 2016 – 2026 (US$ Mn)
FIG. 13 Global Retail Pharmacy Market for AS, 2016 – 2026 (US$ Mn)
FIG. 14 Global E-Commerce Market for AS, 2016 – 2026 (US$ Mn)
FIG. 15 U.S. AS Market, 2016 – 2026 (US$ Mn)
FIG. 16 Canada AS Market, 2016 – 2026 (US$ Mn)
FIG. 17 U.K. AS Market, 2016 – 2026 (US$ Mn)
FIG. 18 Germany AS Market, 2016 – 2026 (US$ Mn)
FIG. 19 Rest of Europe AS Market, 2016 – 2026 (US$ Mn)
FIG. 20 China AS Market, 2016 – 2026 (US$ Mn)
FIG. 21 Japan AS Market, 2016 – 2026 (US$ Mn)
FIG. 22 Rest of Asia Pacific AS Market, 2016 – 2026 (US$ Mn)
FIG. 23 Brazil AS Market, 2016 – 2026 (US$ Mn)
FIG. 24 Mexico AS Market, 2016 – 2026 (US$ Mn)
FIG. 25 Rest of Latin America AS Market, 2016 – 2026 (US$ Mn)
FIG. 26 GCC AS Market, 2016 – 2026 (US$ Mn)
FIG. 27 Rest of MEA AS Market, 2016 – 2026 (US$ Mn)

TABLE 1 Global Asthma Spacers (AS) Market Portraiture
TABLE 2 Global AS Market, by Product, 2016 – 2026 (US$ Mn)
TABLE 3 Global AS Market , by Distribution Channel, 2016 – 2026 (US$ Mn)
TABLE 4 Global AS Market, by Geography, 2016 – 2026 (US$ Mn)
TABLE 5 North America AS Market, by Product, 2016 – 2026 (US$ Mn)
TABLE 6 North America AS Market, by Distribution Channel, 2016 – 2026 (US$ Mn)
TABLE 7 North America AS Market, by Country, 2016 – 2026 (US$ Mn)
TABLE 8 Europe AS Market, by Product, 2016 – 2026 (US$ Mn)
TABLE 9 Europe AS Market, by Distribution Channel, 2016 – 2026 (US$ Mn)
TABLE 10 Europe AS Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 11 Asia Pacific AS Market, by Product, 2016 – 2026 (US$ Mn)
TABLE 12 Asia Pacific AS Market, by Distribution Channel, 2016 – 2026 (US$ Mn)
TABLE 13 Asia Pacific AS Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 14 Latin America AS Market, by Product, 2016 – 2026 (US$ Mn)
TABLE 15 Latin America AS Market, by Distribution Channel, 2016 – 2026 (US$ Mn)
TABLE 16 Latin America AS Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 17 Middle East and Africa AS Market, by Product, 2016 – 2026 (US$ Mn)
TABLE 18 Middle East and Africa AS Market, by Distribution Channel, 2016 – 2026 (US$ Mn)
TABLE 19 Middle East and Africa AS Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 20 AstraZeneca, Plc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 21 Allergan, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 22 CONMED Corporation: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 23 Clement Clarke International Limited: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 24 GlaxoSmithkline, Plc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 25 Koninklijke Philips N.V.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 26 Medical Developments International: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 27 Merck & Co., Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 28 PARI Respiratory Equipment, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 29 Trudell Medical International: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)

Choose License Type
Connect With Us
+1-800-361-8290
24/7 Research Support

Our Clients